A detailed history of Clearstead Trust, LLC transactions in Incyte Corp stock. As of the latest transaction made, Clearstead Trust, LLC holds 141 shares of INCY stock, worth $14,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141
Previous 181 22.1%
Holding current value
$14,685
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$67.27 - $86.96 $2,690 - $3,478
-40 Reduced 22.1%
141 $11,000
Q2 2025

Aug 08, 2025

BUY
$55.17 - $71.22 $9,985 - $12,890
181 New
181 $12,000
Q1 2020

May 12, 2020

SELL
$63.18 - $85.97 $6,065 - $8,253
-96 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$73.04 - $95.72 $3,652 - $4,786
50 Added 108.7%
96 $8,000
Q2 2019

Jul 31, 2019

BUY
$73.52 - $88.7 $3,381 - $4,080
46 New
46 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Clearstead Trust, LLC Portfolio

Follow Clearstead Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.